 Kendra Conzen
Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 19 | 2024 | 795 | 2.490 |
Why?
| | Tissue Donors | 4 | 2025 | 386 | 0.790 |
Why?
| | Living Donors | 9 | 2023 | 287 | 0.740 |
Why?
| | Obesity, Morbid | 4 | 2020 | 238 | 0.740 |
Why?
| | Venous Thrombosis | 2 | 2021 | 158 | 0.660 |
Why?
| | Liver Cirrhosis | 2 | 2020 | 273 | 0.630 |
Why?
| | Portal Vein | 2 | 2021 | 105 | 0.570 |
Why?
| | Postoperative Complications | 4 | 2022 | 2479 | 0.560 |
Why?
| | Kidney Transplantation | 4 | 2024 | 604 | 0.500 |
Why?
| | Transplant Recipients | 3 | 2023 | 151 | 0.500 |
Why?
| | End Stage Liver Disease | 2 | 2020 | 77 | 0.460 |
Why?
| | Gastric Bypass | 3 | 2020 | 107 | 0.440 |
Why?
| | Cholestasis | 2 | 2016 | 230 | 0.410 |
Why?
| | Decompression, Surgical | 1 | 2011 | 98 | 0.360 |
Why?
| | Catheterization | 1 | 2011 | 167 | 0.360 |
Why?
| | Drainage | 1 | 2011 | 165 | 0.350 |
Why?
| | Donor Selection | 3 | 2025 | 74 | 0.340 |
Why?
| | Tissue Plasminogen Activator | 2 | 2023 | 220 | 0.340 |
Why?
| | Reperfusion Injury | 4 | 2014 | 262 | 0.340 |
Why?
| | Liver | 9 | 2023 | 1827 | 0.320 |
Why?
| | Graft Survival | 6 | 2023 | 503 | 0.310 |
Why?
| | Perioperative Care | 2 | 2017 | 149 | 0.230 |
Why?
| | Kidney Failure, Chronic | 2 | 2020 | 535 | 0.220 |
Why?
| | Graft Rejection | 2 | 2020 | 557 | 0.220 |
Why?
| | Tissue and Organ Procurement | 3 | 2025 | 288 | 0.220 |
Why?
| | Informed Consent | 1 | 2024 | 174 | 0.200 |
Why?
| | Thrombelastography | 2 | 2020 | 148 | 0.200 |
Why?
| | Fatty Liver | 3 | 2014 | 232 | 0.200 |
Why?
| | Treatment Outcome | 7 | 2024 | 10163 | 0.190 |
Why?
| | Organ Transplantation | 1 | 2025 | 219 | 0.190 |
Why?
| | Body Mass Index | 2 | 2024 | 2262 | 0.190 |
Why?
| | Reperfusion | 1 | 2020 | 35 | 0.170 |
Why?
| | Waiting Lists | 2 | 2025 | 238 | 0.170 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 45 | 0.170 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 79 | 0.170 |
Why?
| | Predictive Value of Tests | 4 | 2020 | 1936 | 0.160 |
Why?
| | Blood Coagulation | 1 | 2020 | 226 | 0.150 |
Why?
| | Blood Coagulation Disorders | 1 | 2020 | 162 | 0.150 |
Why?
| | Humans | 28 | 2025 | 128524 | 0.150 |
Why?
| | Resuscitation | 1 | 2020 | 240 | 0.150 |
Why?
| | Telomerase | 1 | 2020 | 231 | 0.150 |
Why?
| | Transplantation, Homologous | 3 | 2020 | 396 | 0.150 |
Why?
| | Phlebography | 1 | 2017 | 36 | 0.140 |
Why?
| | Incidental Findings | 1 | 2017 | 80 | 0.140 |
Why?
| | Asymptomatic Diseases | 1 | 2017 | 85 | 0.140 |
Why?
| | Ultrasonography, Doppler | 1 | 2017 | 119 | 0.140 |
Why?
| | Allografts | 1 | 2017 | 137 | 0.140 |
Why?
| | Bariatric Surgery | 1 | 2020 | 190 | 0.140 |
Why?
| | Anticoagulants | 2 | 2021 | 613 | 0.140 |
Why?
| | Retrospective Studies | 8 | 2023 | 14460 | 0.130 |
Why?
| | Simulation Training | 1 | 2018 | 82 | 0.130 |
Why?
| | Sex Factors | 2 | 2024 | 1949 | 0.130 |
Why?
| | General Surgery | 1 | 2018 | 157 | 0.130 |
Why?
| | Male | 14 | 2024 | 62883 | 0.130 |
Why?
| | Surgeons | 1 | 2020 | 274 | 0.130 |
Why?
| | Airway Extubation | 1 | 2016 | 54 | 0.120 |
Why?
| | Vascular Surgical Procedures | 1 | 2018 | 293 | 0.120 |
Why?
| | Adult | 11 | 2024 | 35315 | 0.120 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2014 | 11 | 0.120 |
Why?
| | Missouri | 2 | 2011 | 66 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 2 | 2017 | 2521 | 0.120 |
Why?
| | Parents | 2 | 2020 | 1306 | 0.120 |
Why?
| | Gastrectomy | 3 | 2020 | 99 | 0.120 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2016 | 144 | 0.120 |
Why?
| | Hospitals, University | 1 | 2014 | 175 | 0.110 |
Why?
| | Burnout, Professional | 1 | 2020 | 408 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2014 | 182 | 0.110 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 436 | 0.110 |
Why?
| | Middle Aged | 9 | 2024 | 30893 | 0.110 |
Why?
| | Reoperation | 2 | 2016 | 550 | 0.110 |
Why?
| | Female | 11 | 2024 | 68127 | 0.110 |
Why?
| | Time Factors | 4 | 2020 | 6503 | 0.100 |
Why?
| | Registries | 1 | 2020 | 1878 | 0.100 |
Why?
| | Cholangiography | 1 | 2011 | 17 | 0.100 |
Why?
| | Survival Analysis | 1 | 2014 | 1265 | 0.090 |
Why?
| | Radiographic Image Enhancement | 1 | 2011 | 52 | 0.090 |
Why?
| | Molecular Chaperones | 1 | 2012 | 172 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 634 | 0.090 |
Why?
| | Clinical Competence | 1 | 2018 | 1014 | 0.090 |
Why?
| | Prevalence | 1 | 2017 | 2549 | 0.090 |
Why?
| | Fibrinolysis | 2 | 2023 | 133 | 0.090 |
Why?
| | United States | 4 | 2024 | 13876 | 0.090 |
Why?
| | Neoplasms | 1 | 2025 | 2465 | 0.090 |
Why?
| | Follow-Up Studies | 2 | 2020 | 4898 | 0.080 |
Why?
| | Liver Diseases | 1 | 2012 | 285 | 0.080 |
Why?
| | Mutation | 1 | 2020 | 3692 | 0.080 |
Why?
| | Hypoxia | 1 | 2016 | 1031 | 0.080 |
Why?
| | Prospective Studies | 4 | 2022 | 7043 | 0.080 |
Why?
| | Endoplasmic Reticulum | 1 | 2011 | 260 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2014 | 1108 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2011 | 412 | 0.070 |
Why?
| | Imaging, Three-Dimensional | 1 | 2011 | 534 | 0.070 |
Why?
| | Stents | 1 | 2011 | 504 | 0.070 |
Why?
| | Hepatectomy | 2 | 2023 | 207 | 0.070 |
Why?
| | Heart Failure | 1 | 2020 | 2150 | 0.070 |
Why?
| | Proteomics | 1 | 2012 | 1004 | 0.060 |
Why?
| | Prognosis | 2 | 2024 | 3780 | 0.060 |
Why?
| | Risk Assessment | 1 | 2014 | 3256 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2012 | 3943 | 0.060 |
Why?
| | Hepatitis C Antibodies | 1 | 2004 | 9 | 0.060 |
Why?
| | Immunodominant Epitopes | 1 | 2004 | 28 | 0.060 |
Why?
| | Cohort Studies | 1 | 2014 | 5369 | 0.060 |
Why?
| | Choledochostomy | 1 | 2022 | 11 | 0.050 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2022 | 27 | 0.050 |
Why?
| | Antibody Formation | 1 | 2004 | 287 | 0.050 |
Why?
| | Bile Ducts | 1 | 2022 | 67 | 0.050 |
Why?
| | Hepacivirus | 1 | 2004 | 234 | 0.050 |
Why?
| | Rats, Zucker | 2 | 2012 | 30 | 0.050 |
Why?
| | Creatinine | 1 | 2023 | 475 | 0.050 |
Why?
| | Dabigatran | 1 | 2021 | 21 | 0.050 |
Why?
| | Intraoperative Period | 1 | 2020 | 53 | 0.040 |
Why?
| | Child | 3 | 2021 | 20721 | 0.040 |
Why?
| | Computer Systems | 1 | 2020 | 44 | 0.040 |
Why?
| | Viscosity | 1 | 2020 | 89 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2020 | 109 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 2020 | 145 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2011 | 3366 | 0.040 |
Why?
| | Postoperative Period | 1 | 2020 | 322 | 0.040 |
Why?
| | Nephrectomy | 1 | 2020 | 159 | 0.040 |
Why?
| | Obesity | 2 | 2024 | 2860 | 0.040 |
Why?
| | Aged | 3 | 2025 | 21971 | 0.040 |
Why?
| | Critical Care | 1 | 2023 | 544 | 0.040 |
Why?
| | Infant | 1 | 2011 | 8913 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 150 | 0.040 |
Why?
| | Child, Preschool | 1 | 2011 | 10373 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 273 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 5346 | 0.030 |
Why?
| | Risk Factors | 2 | 2024 | 9727 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1872 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 759 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2019 | 398 | 0.030 |
Why?
| | Shock | 1 | 2016 | 95 | 0.030 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2014 | 40 | 0.030 |
Why?
| | Weight Loss | 1 | 2020 | 723 | 0.030 |
Why?
| | Erythrocyte Transfusion | 1 | 2016 | 182 | 0.030 |
Why?
| | Cause of Death | 1 | 2016 | 391 | 0.030 |
Why?
| | Quality Improvement | 1 | 2022 | 1100 | 0.030 |
Why?
| | Hemoglobins | 1 | 2016 | 336 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2619 | 0.030 |
Why?
| | Rats | 2 | 2012 | 5168 | 0.030 |
Why?
| | Warm Ischemia | 1 | 2012 | 12 | 0.030 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 96 | 0.030 |
Why?
| | Databases, Protein | 1 | 2012 | 61 | 0.020 |
Why?
| | Transaminases | 1 | 2012 | 23 | 0.020 |
Why?
| | Tissue Culture Techniques | 1 | 2012 | 68 | 0.020 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2012 | 101 | 0.020 |
Why?
| | Caspase 3 | 1 | 2012 | 229 | 0.020 |
Why?
| | Taurochenodeoxycholic Acid | 1 | 2011 | 9 | 0.020 |
Why?
| | Activating Transcription Factor 4 | 1 | 2011 | 20 | 0.020 |
Why?
| | Transcription Factor CHOP | 1 | 2011 | 30 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2012 | 475 | 0.020 |
Why?
| | Animals | 4 | 2014 | 34501 | 0.020 |
Why?
| | Organ Size | 1 | 2011 | 440 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2011 | 131 | 0.020 |
Why?
| | Down-Regulation | 1 | 2012 | 629 | 0.020 |
Why?
| | Caspases | 1 | 2011 | 242 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 826 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2012 | 660 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2011 | 374 | 0.020 |
Why?
| | Internship and Residency | 1 | 2018 | 1054 | 0.020 |
Why?
| | Proteome | 1 | 2012 | 431 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 2752 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2011 | 500 | 0.020 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2011 | 259 | 0.020 |
Why?
| | NF-kappa B | 1 | 2011 | 651 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 716 | 0.020 |
Why?
| | Software | 1 | 2011 | 610 | 0.020 |
Why?
| | Biomarkers | 1 | 2016 | 3881 | 0.010 |
Why?
| | Viral Core Proteins | 1 | 2004 | 21 | 0.010 |
Why?
| | Cytokines | 1 | 2012 | 1985 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3023 | 0.010 |
Why?
| | Viral Load | 1 | 2004 | 450 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2012 | 5257 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 814 | 0.010 |
Why?
| | Young Adult | 1 | 2016 | 12320 | 0.010 |
Why?
| | Genotype | 1 | 2004 | 1831 | 0.010 |
Why?
| | Peptides | 1 | 2004 | 909 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 4829 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 20213 | 0.010 |
Why?
| | Mice | 1 | 2012 | 16579 | 0.010 |
Why?
|
|
Conzen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|